We are live on ! Find out more
OPRX icon

OptimizeRx

180 hedge funds and large institutions have $930M invested in OptimizeRx in 2021 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $62.9M | Put options by funds: $39M

45% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 40

24% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 49

10% more funds holding

Funds holding: 163180 (+17)

5.62% more ownership

Funds ownership: 78.77%84.39% (+5.6%)

22% less capital invested

Capital invested by funds: $1.19B → $930M (-$256M)

58% less funds holding in top 10

Funds holding in top 10: 125 (-7)

Holders
180
Holders Change
+17
Holders Change %
+10.43%
% of All Funds
2.77%
Holding in Top 10
5
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-58.33%
% of All Funds
0.08%
New
58
Increased
61
Reduced
49
Closed
40
Calls
$62.9M
Puts
$39M
Net Calls
+$23.9M
Net Calls Change
+$4.65M
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$2.36M +$1.7M +22,385 +143%
Wells Fargo
52
Wells Fargo
California
$2.31M +$435K +5,742 +18%
MC
53
Mount Capital
United Kingdom
$2.29M +$2.79M +36,868 New
Public Sector Pension Investment Board (PSP Investments)
54
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.25M +$2.74M +36,190 New
AR
55
Advisory Research
Illinois
$2.22M +$318K +4,202 +13%
PPA
56
Parametric Portfolio Associates
Washington
$2.18M -$3.34M -44,105 -56%
Swiss National Bank
57
Swiss National Bank
Switzerland
$2.17M +$45.5K +600 +2%
ACA
58
Apis Capital Advisors
New York
$2.11M -$1.21M -16,000 -32%
BA
59
Bridgewater Associates
Connecticut
$2.03M +$314K +4,150 +15%
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$2.03M +$51.1K +675 +2%
Voloridge Investment Management
61
Voloridge Investment Management
Florida
$1.79M +$2.18M +28,774 New
GCA
62
Greenwood Capital Associates
South Carolina
$1.63M +$103K +1,362 +5%
Two Sigma Advisers
63
Two Sigma Advisers
New York
$1.63M -$6.25M -82,500 -76%
Squarepoint
64
Squarepoint
New York
$1.53M +$1.86M +24,578 New
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$1.41M +$55.8K +736 +3%
Barclays
66
Barclays
United Kingdom
$1.4M -$486K -6,407 -22%
Goldman Sachs
67
Goldman Sachs
New York
$1.39M -$3.68M -48,527 -68%
SEI Investments
68
SEI Investments
Pennsylvania
$1.39M -$1.63M -21,529 -49%
RG
69
Renaissance Group
Kentucky
$1.31M -$225K -2,971 -12%
CSS
70
Cubist Systematic Strategies
Connecticut
$1.28M +$97.7K +1,289 +7%
AllianceBernstein
71
AllianceBernstein
Tennessee
$1.21M +$192K +2,534 +15%
CT
72
Clearstead Trust
Maine
$1.21M -$49.3K -650 -3%
YCM
73
Yousif Capital Management
Michigan
$1.17M +$1.42M +18,779 New
Prudential Financial
74
Prudential Financial
New Jersey
$1.17M +$1.42M +18,750 New
New York State Teachers Retirement System (NYSTRS)
75
New York State Teachers Retirement System (NYSTRS)
New York
$1.08M +$1.32M +17,382 New

OPRX Hedge Fund Activity: Q4 2021 in Review

180 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q4 2021, worth a combined $930M — down 22% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new OPRX positions and 40 closed out — a net gain of 18 holders — while 61 added to existing stakes and 49 trimmed.

The largest buyer was BlackRock, adding an estimated $118M. The largest seller was Millennium Management, cutting an estimated $43.9M.

  • 180 institutional investors held OptimizeRx (OPRX) as of Q4 2021, up from 163 in Q3 2021.
  • Funds reported $930M of OptimizeRx stock for Q4 2021, down 22% quarter-over-quarter.
  • 58 funds opened new OptimizeRx positions in Q4 2021 and 40 closed out, a net change of +18 holders.
  • The largest OptimizeRx buyer in Q4 2021 was BlackRock, an estimated $118M added.
  • The largest OptimizeRx seller in Q4 2021 was Millennium Management, an estimated $43.9M sold.

Based on aggregated 13F filings for Q4 2021.